You just read:

Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX® AR-V7 Nucleus Detect™ Test to Predict Treatment Response in Metastatic Disease

News provided by

Genomic Health, Inc.

Feb 26, 2018, 08:00 ET